Latest Breaking News On - Amylyx pharmaceuticals company profile - Page 3 : comparemela.com

Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Short Interest Update

Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nova scotiaUnited statesJamesm fratesRobertw bairdPatrickd yeramianBlackrock incYork mellon corpAmylyx pharmaceuticals company profileAmylyx pharmaceuticals stock performanceGoldman sachs groupPutnam investmentsAmylyx pharmaceuticalsAmylyx pharmaceuticals incInstitutional investors weigh in on amylyx pharmaceuticalsSecurities exchange commissionRoyal bank

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Up 6 6%

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Up 6 6%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesDekabank deutsche girozentraleJamesm fratesRobertw bairdPatrickd yeramianAmylyx pharmaceuticals price performanceSecurities exchange commissionNews ratings for amylyx pharmaceuticals dailySg americas securitiesGoldman sachs groupChina universal asset management coPath wealth partnersAmylyx pharmaceuticals company profileAmylyx pharmaceuticals incDeutsche bank aktiengesellschaftAmylyx pharmaceuticals

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Down 3 3%

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Down 3 3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJustinb kleeJamesm fratesRobertw bairdOsaic holdings incLoring wolcott coolidge fiduciary advisorsAmylyx pharmaceuticals price performanceAmylyx pharmaceuticals company profileNews ratings for amylyx pharmaceuticals dailyRoyal bankGoldman sachs groupInsider activity at amylyx pharmaceuticalsHedge funds weigh in on amylyx pharmaceuticalsSecurities exchange commissionDeutsche bank aktiengesellschaftAmylyx pharmaceuticals inc

Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Short Interest Down 18 3% in December

Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Short Interest Down 18 3% in December
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nova scotiaUnited statesRobertw bairdPatrickd yeramianJustinb kleeVanguard group incAmylyx pharmaceuticals incBlackrock incAmylyx pharmaceuticalsDeutsche bank aktiengesellschaftAmylyx pharmaceuticals company profileMarshall waceStonepine capital managementInstitutional trading of amylyx pharmaceuticalsNews ratings for amylyx pharmaceuticals dailyGoldman sachs group

Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Short Interest Down 10 8% in November

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) was the recipient of a large decrease in short interest in November. As of November 15th, there was short interest totalling 7,070,000 shares, a decrease of 10.8% from the October 31st total of 7,930,000 shares. Approximately 14.2% of the company’s stock are short sold. Based on an […]

United statesAdvisors asset management incAmylyx pharmaceuticalsNews ratings for amylyx pharmaceuticals dailyManufacturers life insurance companyAmylyx pharmaceuticals incAmylyx pharmaceuticals company profileGoldman sachs groupAmylyx pharmaceuticals price performanceWells fargo companyHedge funds weigh in on amylyx pharmaceuticalsRoyal bankGet free reportAsset managementWells fargoAmylyx pharmaceuticals daily